Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: Brain Res. 2019 Jul 4;1721:146303. doi: 10.1016/j.brainres.2019.146303

Figure 1.

Figure 1.

Mean 17β-estradiol and DHEAS concentrations by MDD and menopausal stage, a) Serum estradiol levels in MDD postmenopausal women were significantly lower than non-MDD postmenopausal women and pre/perimenopausal women, regardless of MDD status. As expected, non-MDD postmenopausal women had significantly lower levels of estradiol compared to non-MDD pre/perimenopausal women, b) In non-MDD subjects, men had significantly higher of DHEAS compared to pre/perimenopausal and postmenopausal women. In MDD, men had significantly higher levels of DHEAS compared to postmenopausal women. There were no differences in DHEAS levels between menopausal staging groups in both MDD status. Non-MDD: pre/perimenopause (n = 33), postmenopause (n = 21), men (n = 67); MDD: pre/perimenopause (n = 29), postmenopause (n = 10), men (n = 27). Error bars represent SEM. *p< 0.05.